Clinical practice guidelines for post-mastectomy breast reconstruction: Chinese society of breast surgery (CSBrS) practice guidelines 2021

Title: Clinical practice guidelines for post-mastectomy breast reconstruction: Chinese society of breast surgery (CSBrS) practice guidelines 2021
Edition: Original
Classification: Standard guideline
Field: Treatment
Countries and regions: China
Guidelines users: Clinicians specializing in breast diseases in China.
Evidence classification method: The level of evidence grading system was developed by referring to the GRADE system combined with findings in clinical studies in China. The levels are classified as Category I, II, III, and IV to quantify the evaluation of the reliability of the evidence by experts on the compiling committees. To make these guidelines accessible in clinical practice in China, the expert panel preferentially selected Category I and II evidence, as indicated in the guideline evaluation system.
Development unit: 中华医学会外科学分会乳腺外科学组
Registration time: 2021-06-07
Registration number: IPGRP-2021CN145
Purpose of the guideline: Breast loss brings psychological trauma for breast cancer patients that can seriously affect their quality of life. The value of breast reconstruction for breast cancer patients with relevant indications is widely recognized. To promote the standardization of postmastectomy breast reconstruction in China, the Chinese Society of Breast Surgeons (CSBrS) of the Surgery Branch of the Chinese Medical Association determined the key issues in postmastectomy breast reconstruction in clinical practice through a literature review and expert discussions. It then developed the CSBrS Clinical Practice Guidelines for Postmastectomy Breast Reconstruction (2021 version) by systematically assessing relevant published evidence according to the Grading of Recommendations Assessment, Development and Evaluation recommendations and based on the accessibility of clinical practice in China. This guideline provides a reference for Chinese breast surgeons.